1035 related articles for article (PubMed ID: 17977701)
41. Compaction, compression and drug release properties of diclofenac sodium and ibuprofen pellets comprising xanthan gum as a sustained release agent.
Santos H; Veiga F; Pina ME; Sousa JJ
Int J Pharm; 2005 May; 295(1-2):15-27. PubMed ID: 15898143
[TBL] [Abstract][Full Text] [Related]
42. A mechanistic understanding of compression damage to the dissolubility of coated pellets in tablets.
Hiew TN; Tian YH; Tan HM; Heng PWS
Eur J Pharm Biopharm; 2020 Jan; 146():93-100. PubMed ID: 31786321
[TBL] [Abstract][Full Text] [Related]
43. Aqueous coating dispersion (pseudolatex) of zein improves formulation of sustained-release tablets containing very water-soluble drug.
Li XN; Guo HX; Heinamaki J
J Colloid Interface Sci; 2010 May; 345(1):46-53. PubMed ID: 20129615
[TBL] [Abstract][Full Text] [Related]
44. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
Tabasi SH; Moolchandani V; Fahmy R; Hoag SW
Int J Pharm; 2009 Dec; 382(1-2):1-6. PubMed ID: 19660535
[TBL] [Abstract][Full Text] [Related]
45. Tableting and tablet properties of alginates: characterisation and potential for Soft Tableting.
Schmid W; Picker-Freyer KM
Eur J Pharm Biopharm; 2009 May; 72(1):165-72. PubMed ID: 18992337
[TBL] [Abstract][Full Text] [Related]
46. Development of a multiple-unit tablet containing enteric-coated pellets.
Dreu R; Ilić I; Srčič S
Pharm Dev Technol; 2011 Apr; 16(2):118-26. PubMed ID: 20088675
[TBL] [Abstract][Full Text] [Related]
47. Preparation and in vitro-in vivo evaluation of double layer coated and matrix sustained release pellet formulations of diclofenac potassium.
Fu J; Wang X; Xu L; Meng J; Weng Y; Li G; He H; Tang X
Int J Pharm; 2011 Mar; 406(1-2):84-90. PubMed ID: 21219996
[TBL] [Abstract][Full Text] [Related]
48. A flexible technology for modified-release drugs: multiple-unit pellet system (MUPS).
Abdul S; Chandewar AV; Jaiswal SB
J Control Release; 2010 Oct; 147(1):2-16. PubMed ID: 20493217
[TBL] [Abstract][Full Text] [Related]
49. Formulation and process strategies to minimize coat damage for compaction of coated pellets in a rotary tablet press: A mechanistic view.
Xu M; Heng PWS; Liew CV
Int J Pharm; 2016 Feb; 499(1-2):29-37. PubMed ID: 26748363
[TBL] [Abstract][Full Text] [Related]
50. Modulating pH-independent release from coated pellets: effect of coating composition on solubilization processes and drug release.
Ensslin S; Moll KP; Metz H; Otz M; Mäder K
Eur J Pharm Biopharm; 2009 May; 72(1):111-8. PubMed ID: 19084061
[TBL] [Abstract][Full Text] [Related]
51. Bead compacts. I. Effect of compression on maintenance of polymer coat integrity in multilayered bead formulations.
Altaf SA; Hoag SW; Ayres JW
Drug Dev Ind Pharm; 1998 Aug; 24(8):737-46. PubMed ID: 9876521
[TBL] [Abstract][Full Text] [Related]
52. Characterization of enteric-coated tablets and pellets by two in vitro dissolution methods and by scanning electron microscopy.
Odegårdstuen LI; Bjerknes K; Sande SA; Waaler T
Acta Pharm Nord; 1991; 3(3):163-70. PubMed ID: 1793511
[TBL] [Abstract][Full Text] [Related]
53. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
54. Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms.
Zhu Y; Mehta KA; McGinity JW
Pharm Dev Technol; 2006; 11(3):285-94. PubMed ID: 16895839
[TBL] [Abstract][Full Text] [Related]
55. [Studies on heart-protecting musk pH-dependent gradient-release pellets].
Song HT; Guo T; Zhang RH; Ma Y; Li X; Bi KS
Yao Xue Xue Bao; 2002 Oct; 37(10):812-7. PubMed ID: 12567868
[TBL] [Abstract][Full Text] [Related]
56. Preparation of co-spray dried cushioning agent containing stearic acid for protecting pellet coatings when compressed.
Li X; Xu DS; Li M; Liu L; Heng P
Drug Dev Ind Pharm; 2016; 42(5):788-95. PubMed ID: 26289006
[TBL] [Abstract][Full Text] [Related]
57. Citric acid as a solid-state plasticizer for Eudragit RS PO.
Schilling SU; Shah NH; Malick AW; Infeld MH; McGinity JW
J Pharm Pharmacol; 2007 Nov; 59(11):1493-500. PubMed ID: 17976259
[TBL] [Abstract][Full Text] [Related]
58. Investigation of the drug release and surface morphological properties of film-coated pellets, and physical, thermal and mechanical properties of free films as a function of various curing conditions.
Bhattacharjya S; Wurster DE
AAPS PharmSciTech; 2008; 9(2):449-57. PubMed ID: 18431665
[TBL] [Abstract][Full Text] [Related]
59. The manufacture and characterisation of hot-melt extruded enteric tablets.
Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
[TBL] [Abstract][Full Text] [Related]
60. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
Ghanam D; Kleinebudde P
Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
